| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |